# Clinical Trial to Assess the Importance of Nephrectomy

> **NCT00930033** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 452 (actual)

## Conditions studied

- Metastatic Renal Cell Carcinoma

## Interventions

- **PROCEDURE:** Nephrectomy
- **OTHER:** Sunitinib alone

## Key facts

- **NCT ID:** NCT00930033
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09-09
- **Primary completion:** 2018-10-22
- **Final completion:** 2018-10-22
- **Target enrollment:** 452 (ACTUAL)
- **Last updated:** 2025-09-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00930033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00930033, "Clinical Trial to Assess the Importance of Nephrectomy". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00930033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*